APA (7th ed.) Citation

Xie, F., Zhang, T., Zhang, X., Xu, Z., Qiao, L., Wang, Y., . . . Zhou, J. Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia. BMC.

Chicago Style (17th ed.) Citation

Xie, Fei, Ting-juan Zhang, Xin-long Zhang, Zi-jun Xu, Liang Qiao, Yun Wang, Yang-jing Zhao, Jun Qian, and Jing-dong Zhou. Identification of HOXA9 Methylation as an Epigenetic Biomarker Predicting Prognosis and Guiding Treatment Choice in Acute Myeloid Leukemia. BMC.

MLA (9th ed.) Citation

Xie, Fei, et al. Identification of HOXA9 Methylation as an Epigenetic Biomarker Predicting Prognosis and Guiding Treatment Choice in Acute Myeloid Leukemia. BMC.